Evidence map›Paper›PMID 25818050›Full record

ArticleNeuroscience2015

Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.

C Nocjar, K D Alex, A Sonneborn, A I Abbas, B L Roth, E A Pehek

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The Selective 5HTSynapse (New York, N.Y.) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Effects of (-)-MBP, a novel 5-HTPharmacology research & perspectives · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Endogenous Serotonin 5-HTACS chemical neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

C NocjarLouis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA; Department of Psychiatry, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: cxn18@case.edu.
K D AlexLouis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA; Department of Neurosciences, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: ktlx11@yahoo.com.
A SonnebornLouis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA. Electronic address: sonneborn.alex@gmail.com.
A I AbbasDepartment of Psychiatry, Columbia University, New York, NY 10032, USA; Division of Integrative Neuroscience, New York State Psychiatric Institute, New York, NY 10032, USA. Electronic address: atheirabbas@gmail.com.
B L RothDepartment of Pharmacology, University of North Carolina-Chapel Hill School of Medicine, 120 Mason Farm Road, 4072 Genetic Medicine Building, Campus Box 7365, Chapel Hill, NC 27599-7365, USA. Electronic address: bryan_roth@med.unc.edu.
E A PehekLouis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, USA; Department of Neurosciences, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA; Department of Psychiatry, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: eap6@case.edu.
Case Western Reserve University · USLouis Stokes Cleveland VA Medical Center · USNew York Psychoanalytic Society and Institute · USUniversity of North Carolina at Chapel Hill · US

Funding

Screening CoreU19MH082441 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, MARC G., CARON, MARC G. · 2007 to 2016
$15.2M
Targeting and Trafficking of 5-HT2A Serotonin ReceptorsR01MH061887 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROTH, BRYAN L. · 2000 to 2014
$4.5M
Serotonergic Regulation of Mesocortical Dopamine ReleaseR01MH052220 · NIMH · CASE WESTERN RESERVE UNIVERSITY · PI PEHEK, ELIZABETH A · 2001 to 2004
$632k
NIMH NIH HHS R01 MH052220NIMH NIH HHS R01 MH061887NIMH NIH HHS R01MH52220NIMH NIH HHS R01MH61887NIMH NIH HHS U19 MH082441
6 · The paper itself

Abstract

Neural function within the medial prefrontal cortex (mPFC) regulates normal cognition, attention and impulse control, implicating neuroregulatory abnormalities within this region in mental dysfunction related to schizophrenia, depression and drug abuse. Both serotonin-2A (5-HT2A) and -2C (5-HT2C) receptors are known to be important in neuropsychiatric drug action and are distributed throughout the mPFC. However, their interactive role in serotonergic cortical regulation is poorly understood. While the main signal transduction mechanism for both receptors is stimulation of phosphoinositide production, they can have opposite effects downstream. 5-HT2A versus 5-HT2C receptor activation oppositely regulates behavior and can oppositely affect neurochemical release within the mPFC. These distinct receptor effects could be caused by their differential cellular distribution within the cortex and/or other areas. It is known that both receptors are located on GABAergic and pyramidal cells within the mPFC, but it is not clear whether they are expressed on the same or different cells. The present work employed immunofluorescence with confocal microscopy to examine this in layers V-VI of the prelimbic mPFC. The majority of GABA cells in the deep prelimbic mPFC expressed 5-HT2C receptor immunoreactivity. Furthermore, most cells expressing 5-HT2C receptor immunoreactivity notably co-expressed 5-HT2A receptors. However, 27% of 5-HT2C receptor immunoreactive cells were not GABAergic, indicating that a population of prelimbic pyramidal projection cells could express the 5-HT2C receptor. Indeed, some cells with 5-HT2C and 5-HT2A receptor co-labeling had a pyramidal shape and were expressed in the typical layered fashion of pyramidal cells. This indirectly demonstrates that 5-HT2C and 5-HT2A receptors may be commonly co-expressed on GABAergic cells within the deep layers of the prelimbic mPFC and perhaps co-localized on a small population of local pyramidal projection cells. Thus a complex interplay of cortical 5-HT2A and 5-HT2C receptor mechanisms exists, which if altered, could modulate efferent brain systems implicated in mental illness.

Indexed as

AnimalsCell CountGlutamate DecarboxylaseMaleNeuronsParvalbuminsPrefrontal CortexRatsRats, Sprague-DawleyReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CGlutamate Decarboxylaseglutamate decarboxylase 1ParvalbuminsReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2C5-HT5-HT(2A) receptor5-HT(2C) receptorGABAimmunofluorescencepyramidal

Identifiers

PMID25818050
PMCPMC4595040
OpenAlexW1988466178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.